ArticleDiagnostics (Basel, Switzerland)2023

Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence.

Keita Nakane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.